About Careers MedBlog Contact us

European Union-Funded Project to Engineer Bacteria for Novel Vaccines

by Bidita Debnath on May 11, 2015 at 1:38 AM
Font : A-A+

European Union-Funded Project to Engineer Bacteria for Novel Vaccines

A European Union-funded project is combining biotechnology and gene engineering to design novel vaccines based on the bacterium Mycoplasma pneumoniae.

The Mycosplasma bacteria are the smallest self-replicating organisms.


They lack a cell wall, making them resistant to almost all antibiotics, and infections caused by Mycoplasma in livestock, result in huge losses in Europe and throughout the world.

Although there are vaccines against two species of Mycoplasma that affect pigs and poultry, no vaccines exist for many Mycoplasma species that affect not only livestock but also pets and humans.

The eight-million Euro MycoSynVac project will see researchers engineer a universal vaccine chassis that will be free of virulence and optimized for fast growth in a serum-free medium.

This chassis will be used to create specific vaccines against two highly detrimental pathogens that are causing suffering in livestock animals and large financial losses to the animal industry.

The chassis will also set the basis for other potential applications, such as for cell therapy and infectious lung disease treatment.

"We will engineer a new bacteria to be used as a vaccine. We will remove the genes that make the bacteria pathogenic and improve the chassis for an optimized growth in a serum-free medium," said Luis Serrano, director of the Centre for Genomic Regulation (CRG) and co-coordinator of the project.

By expressing specific harmless antigens from one or more pathogens, we will be able to create targeted vector vaccines, he said.

Researchers also foresee that the generated mycoplasma chassis can be further developed for other vaccines and will have other potential applications, such as in cell therapy and infectious lung disease therapy.

Source: IANS


Recommended Reading

Latest Research News

 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune Diseases Affect One in Ten: Study
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Remarkable Journey of Transforming Lives With Brain Pacemaker
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
What Are the Effects of Healthy Lifestyle on Osteoarthritis?
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

European Union-Funded Project to Engineer Bacteria for Novel Vaccines Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests